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A mutation in VPS15 (PIK3R4) causes a ciliopathy
and affects IFT20 release from the cis-Golgi
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Ciliopathies are a group of diseases that affect kidney and retina among other organs. Here,
we identify a missense mutation in PIK3R4 (phosphoinositide 3-kinase regulatory subunit 4,
named VPS15) in a family with a ciliopathy phenotype. Besides being required for trafﬁcking
and autophagy, we show that VPS15 regulates primary cilium length in human ﬁbroblasts, as
well as ciliary processes in zebraﬁsh. Furthermore, we demonstrate its interaction with the
golgin GM130 and its localization to the Golgi. The VPS15-R998Q patient mutation impairs
Golgi trafﬁcking functions in humanized yeast cells. Moreover, in VPS15-R998Q patient
ﬁbroblasts, the intraﬂagellar transport protein IFT20 is not localized to vesicles trafﬁcking to
the cilium but is restricted to the Golgi. Our ﬁndings suggest that at the Golgi, VPS15 and
GM130 form a protein complex devoid of VPS34 to ensure the IFT20-dependent sorting and
transport of membrane proteins from the cis-Golgi to the primary cilium.
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T
he primary cilium is a non-motile polarized micro-
tubule-based hair-like structure protruding from the
surface of many eukaryotic cells, with the exception of
higher plants and fungi. Primary cilia are sensing extracellular
molecules and environmental stimuli. By dynamic exchanges
of signalling molecules, they convert extracellular signals to
intracellular responses1. They have a pivotal role in different
signalling cascades: the Sonic Hedgehog, Wnt, Notch signalling
and mTOR pathways. In humans, cilia dysfunctions can result in
developmental defects such as situs inversus, polydactyly or
central nervous system abnormalities as well as progressive
organ alteration, including, retinal degeneration or cystic kidneys
and form a class of clinically and genetically heterogeneous
diseases termed ciliopathies2,3. Ciliopathies are due to disease-
causing mutations in genes encoding ciliary proteins and their
study has revealed various actors of ciliary biogenesis and
function, as well as unexpected links to previously characterized
cellular pathways2.
Early stages of ciliogenesis are characterized by the maturation
of the mother centriole into a basal body as it migrates from its
perinuclear position to the plasma membrane, followed by cilium
elongation after extension of the axoneme4. Axoneme extension
and cilia signalling largely rely on the evolutionary conserved
mechanism of intraﬂagellar transport (IFT) via the IFT-A/B
protein complexes that ensure bidirectional trafﬁcking along the
ciliary axoneme, by using kinesin-2 (anterograde) and dynein
(retrograde) molecular motors. Among these IFTs, only the
IFT20 protein has a dual localization at Golgi and basal body.
At the Golgi, IFT20 ensures the sorting of ciliary cargo from the
cis-Golgi to the base of the cilium5,6. Ciliary membrane proteins
are either delivered from the Golgi to the plasma membrane
before moving towards the basal body or they are directly
transported from the Golgi to the cilium4. At the base of the
cilium, a complex termed BBSome formed by a subset of
BBS proteins recognizes ciliary cargoes7,8. The BBSome shares
structural features with clathrin and coatomer coats (COPI
and COPII) forming a coat on liposome membranes once
recruited by Arl6-GTP7,8.
Here, we report the identiﬁcation of a mutation in the
PIK3R4/VPS15 gene (MIM 602610, NM_014602.2: c.2993G4A,
R998Q) in three affected siblings with a ciliopathy phenotype.
VPS15 (Vacuolar Protein Sorting 15) encodes the phos-
phoinositide 3-kinase regulatory subunit 4 required for the
synthesis of the lipid phosphatidylinositol 3-phosphate
(PtdIns3P). VPS15 was ﬁrst identiﬁed and characterized in
yeast Saccharomyces cerevisiae after its isolation in different
genetic screens performed to identify proteins required for
vacuolar protein sorting (VPS)9. VPS15 binds to and regulates the
class III PtdIns3P lipid kinase VPS34/PIK3C3 converting
PtdIns to PtdIns3P. VPS15 in association with VPS34 is
involved in two well-studied protein complexes conserved from
yeast to mammals, the UVRAG/Beclin1 and Atg14L/Beclin1
complex required for membrane trafﬁcking and autophagy,
respectively10,11. In metazoan, VPS15 is an essential gene since
drosophila homozygous deletion mutant and whole-body
Vps15-deﬁcient mice (Vps15 / ) display early L3 larval stage
or early-embryonic lethality a phenotype similar to the one
observed for Vps34 / mice11,12. The VPS15 protein is
composed of an amino (N)-terminal protein kinase, a HEAT
repeat, a coiled coil and seven carboxy (C)-terminal WD40
domains.
In the present work, we describe for the ﬁrst time patients with
a ciliopathy phenotype carrying a mutation in VPS15 as well as
the link between VPS15 and cilia trafﬁcking by using three model
organisms (human, zebraﬁsh and yeast). We show that the
VPS15-R998Q patient mutation affects the primary cilium length
in human ﬁbroblasts, induces axial curvature and kidney cysts in
zebraﬁsh embryos and impairs the dominant-negative Golgi to
vacuole trafﬁcking phenotype of hVPS15 in yeast cells. We also
show that in human ﬁbroblasts a pool of VPS15 localizes to the
Golgi and interacts with the golgin GM130 ensuring
efﬁcient loading of IFT20 in vesicles addressed from the
cis-Golgi to the basal body of the cilium. This work suggests
that VPS15 and GM130 function together at the Golgi to ensure
the IFT20-dependent sorting and transport of proteins addressed
to the ciliary membrane.
Results
A mutation in the VPS15 gene in a family with a ciliopathy.
Three siblings (patients II.1, II.3 and II.5 in Fig. 1a) born from
Algerian parents (originating from the same village and with high
probability of distant consanguinity) were referred for early-onset
retinal degeneration and progressive renal disease (CARGO, Rare
Eye Diseases Center, Strasbourg University Hospital; Fig. 1b).
The proband (II.1) was reported with night blindness as well as
progressive visual impairment since the age of 5. An unrecordable
electroretinogram at age 11 conﬁrmed the diagnosis of
retinitis pigmentosa. Fundus examinations revealed progressive
widespread retinal dystrophy associated with pigment migration
(Fig. 1c). He also developed progressive renal failure with
glomerular and tubular dysfunctions followed by progressive
kidney atrophy reminiscent of nephronophthysis requiring
dialysis at age 24. General clinical examination showed a small
stature ( 3 s.d.) due to growth hormone deﬁciency, overweight
(BMI 28 kgm 2), prognathism (similar to his father suggesting
an independent dominant trait), enlarged hands with
brachydactyly and clinodactyly of the ﬁfth digit, and mild
learning difﬁculties (Fig. 1b). The younger sister (II.3) at age 6
presented growth delay ( 2 s.d.) and was diagnosed with
retinitis pigmentosa. Besides her history of brachial plexus palsy
at birth and dysmenorrhea at age 19, she presented the same
physical features as her brother (prognathism, enlarged hands,
bradymetacarpy and brachymesophalangy, and clinodactyly of
the ﬁfth ﬁnger). She was diagnosed with kidney manifestations at
age 14 and had moderate renal dysfunction at the age 19.
Abdominal magnetic resonance imaging (MRI) revealed reduced
size kidneys (9 cm axial length for the right and 8 cm for the left;
normal axial length 12 cm) ﬁlled with multiple corticomedullary
microcysts and a larger cyst (3 cm) in the left kidney (Fig. 1d).
The kidney biopsy showed a diffuse tubulo-interstitial
nephropathy. The youngest sibling (II.5) had a history of con-
genital hypotonia, brachial plexus palsy at birth, language delay
and mild learning difﬁculties (Fig. 1b). Fundus examination
performed at age 4 revealed retinitis pigmentosa, conﬁrmed by an
unrecordable electroretinogram. General clinical examination
revealed the same gestalt as probands II.1 and II.3. Proteinuria
appeared at age 4 and he is now developing a progressive
nephropathy. Thus, three out of ﬁve siblings of this family
exhibited typical ciliopathy features of retinitis pigmentosa,
renal dysfunction and developmental anomalies prompting for
molecular investigations to identify the causal mutation.
To identify the genetic mutation responsible for the disease, we
screened a panel of 30 ciliopathy-related genes and we found
no mutations. The genome-wide homozygosity mapping
combined to whole-exome sequencing of the three affected
siblings (II.1, II.3, II.5) and the healthy sister (II.4) revealed only
four homozygous regions speciﬁc to the three affected
individuals: two on chromosome 3 and one on chromosomes 6
and 20 (Supplementary Fig. 1). Sequencing data processing and
variant calling (SNP and InDels) with the Genome Analysis
Toolkit revealed 60,612 to 63,887 genetic variants per proband
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Figure 1 | Pedigree and clinical presentation of the family affected by VPS15-R998Q mutation. (a) Pedigree of the family with affected members in black
and results of Sanger sequencing conﬁrming co-segregation of the mutation with the disease. (b) Main clinical features of II.1, II.3 and II.5 affected individuals.
(c) Fundus photographs (respectively right eye, left eye) of II.3 and II.5 individuals showing on the left sides a central view of the retina with the posterior pole
of each right eye of the patients with mild narrowing of the retinal vasculature and moderate visible changes at the macula (best seen for II.3). On the right
sides, peripheral views show high level of pigment epithelium heterogeneity/atrophy with pigment migrations typical for retinitis pigmentosa (arrows).
(d) Abdominal MRI (SPAIR fat-suppression technique, Achieva PHILIPS 3 T) of II.3 and of a normal individual (Ctrl) for comparison (long and short axis are
drawn on the normal kidney view). Coronal view of the kidneys showing the very reduced length of patient II.3 kidneys, the right and left kidneys being 9.1 and
8.2 cm on long axis and 4.3 and 4.1 cm on short axis, compared with the mean 11 cm (long axis) and 5 cm (short axis) length for the normal kidneys. The MRI
also shows corticomedullary microcysts as well as larger cysts (arrows), the one in the left kidney with 3 cm in diameter. (e) Schematic representation of the
gene, mRNA and VPS15 protein with the different protein domains and the location of the mutation indicated in red.
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(Supplementary Table 1). Variant ﬁltering using stringent criteria
reduced the number of genetics variants to respectively 1,085,
793, 1,124 and 2,009 variants per proband (Supplementary
Table 1). To identify variants consistent with autosomal recessive
disease inheritance, we kept only compound heterozygous or
homozygous variants, reducing the number of variants to two
compound heterozygous variants (in the AK9 and RECQL4/
MFSD3 genes) and one homozygous variant (in the PIK3R4
gene). Using manual curation based on the known biological,
physiological or functional relevance to the disease of the
candidate genes, we were left with a single homozygous variant
in the PIK3R4 gene, named herein VPS15: p.Arg998Gln,
c.2993G4A, Chr3:(GRCh37):g.130422672C4T. The variant
and its cosegregation with the phenotype in the family was
conﬁrmed by Sanger sequencing. Overall, deleterious or poten-
tially pathogenic homozygous or compound heterozygous
variants were not found in 382 patients with presumed ciliopathy
and yet unknown molecular origin (our databases and the
databases of three laboratories specialized in ciliopathies and
other rare genetic diseases) and in 7,360 patients screened for
other rare diseases (Institut IMAGINE). The PolyPhen-2
(polymorphism phenotyping v2) software, a tool analysing
impact of amino acid substitutions on protein structure and
function13, predicts that this R998Q substitution is ‘probably
damaging’ with a HumVar score 0.994. The residue Arg998 is in
the ﬁrst WD40 repeat of the VPS15 protein (Fig. 1e), a domain
known to be important for protein–protein interactions. Indeed,
the WD40 domain of the yeast Vps15 protein is sufﬁcient to bind
Atg14 (ref. 14), bridges the Vps38/Atg6 heterodimer to form the
Vps15-Vps34 complex II (ref. 15) and in human cells the NRBF2
protein interacts with the VPS15 WD40 domain16.
Cilia are shorter in VPS15-R998Q patient ﬁbroblasts. Some
ciliopathies present with impaired ciliogenesis or shorter cilia,
while others are characterized by longer cilia. To investigate
whether the symptoms observed in patients were associated with a
ciliary phenotype, skin ﬁbroblasts from patients II.1, II.3 and II.5
and age-matched control ﬁbroblasts were grown to conﬂuence in
medium containing 10% fetal calf serum (FCS), then washed and
starved by serum deprivation for 24 h ( FCS) to induce growth
arrest and cilium formation. Primary cilia were labelled with an
antibody directed against acetylated a-tubulin highlighting the
axoneme (Fig. 2). Percentage of ciliated cells was similar in control
(80%) and patient cells (73%). However, measuring cilium length
in the age-matched healthy controls and in the patient ﬁbroblasts
showed that in cells from patients II.1, II.3 and II.5, the cilia were
about 50% shorter than in the corresponding control cells (Fig. 2).
Fibroblasts from a patient carrying a homozygous BBS4 deletion
were used as positive control17. As expected, the cilium length of
BBS4 / cells was reduced, however to a lesser extent compared
with the VPS15-R998Q patient cells. This result shows that skin
ﬁbroblasts from patients carrying the VPS15-R998Q mutation
present a ciliary phenotype characterized by shorter primary
cilia. To conﬁrm that this phenotype is due to the missense
mutation in VPS15, skin ﬁbroblasts from patients were transfected
with a plasmid expressing 3xHA tagged VPS15 cDNA. The
proper expression of VPS15-HA from this plasmid was checked
by western blot after transfection of the retinal pigment
epithelial cell line hTERT-RPE1 (Supplementary Fig. 2A), then
by immunoﬂuorescence in control ﬁbroblasts grown in complete
medium or serum-deprived to conﬁrm the Golgi localization
(Supplementary Fig. 2B).
Finally, the patient ﬁbroblasts were either mock transfected or
transfected with the VPS15-HA construct 6 h before serum
deprivation. Twenty-four hours post serum deprivation, the cells
were ﬁxed and stained as described above and the cilium length
determined. The VPS15-HA protein was able to rescue the
short-cilium phenotype in all the three patients conﬁrming that
the VPS15-R998Q mutation is responsible for this defect.
Interestingly, while transfection with VPS15-HA and subsequent
serum deprivation was deleterious to all the cells and resulted in
about 70% mortality, the surviving cells appeared to be those with
the lower expression of VPS15-HA, suggesting a negative effect of
VPS15 overexpression.
VPS15-RQ associated with ciliopathy phenotypes in zebraﬁsh.
Zebraﬁsh Danio rerio is a well-established model for human
ciliopathies18. Antisense morpholino injection was used to
elucidate a putative ciliary function of Vps15 in zebraﬁsh by
searching for ciliopathy-related phenotypes (curvature of body axis
and kidney cysts). The zebraﬁsh zvps15/pik3r4 gene
(ENSDARG0000000469) maps to LG16 and has two predicted
splice variants encoding two putative proteins of 1,340 and 1,347
amino acids. Sequencing and BLAST analysis indicated that only
the shorter variant was present (data not shown), encoding a
protein with a high degree of sequence similarity to mammalian
VPS15 (82% identity to hVPS15) with conservation of the R998
residue at position 976 of the zVps15 protein. Furthermore, the
zvps15 transcript was detected in zebraﬁsh embryos from the eight-
cell stage (1.25 h post fertilization (h.p.f.)) to the protruding-mouth
stage (72 h.p.f.) (Supplementary Fig. 3A,B).
To reveal the spatial expression pattern of zvps15, we performed
whole-mount RNA in situ hybridization at 48 h.p.f. Expression of
zvps15 was observed in the head as well as in the pronephric duct
(Supplementary Fig. 3C). Morpholinos directed against the zvps15
start codon (vps15-mo) and control morpholino (vps15cont-mo)
with ﬁve-base mismatch were synthesized. The vps15-mo inhibited
speciﬁcally protein synthesis of a zVps15–GFP fusion protein
(Supplementary Fig. 3D). At 56 h.p.f., 50% of the vps15 morphants
presented a severe curvature of the body axis (Fig. 3a,b).
Co-injection of vps15-mo or vps15cont-mo with a morpholino
directed against p53 messenger RNA (mRNA; p53-mo) did not
rescue the phenotype (Fig. 3b), showing that the phenotype was
not due to morpholino off-targeting mediated through p53
activation19. Moreover, 90% of the vps15 morphants showed
hydrocephalus (Fig. 3a). We also observed the presence of kidney
cysts as well as a cystic dilatation of the region slightly posterior to
the ear at the level of the pectoral ﬁn in 61% of vps15 morphants
(Fig. 3d,e and Supplementary Fig. 3E), a phenotype not due to
activation of p53-mediated apoptosis (Fig. 3e). In most morphants,
we could detect two bilateral pronephric cysts (Fig. 3d).
To assess the speciﬁcity of the morpholino effects and test the
patient VPS15-R998Q missense mutation, we determined whether
the vps15-mo phenotypes associated with cilia dysfunctions (body
axis curvature and kidney cysts) could be rescued by co-injection
of a synthetic zvps15 or zvps15-R976Q mutant mRNA (Fig. 3c,f).
Co-injection of zvps15 wild-type mRNA caused a statistically
signiﬁcant rescue of both phenotypes (body axis curvature and
kidney structure), while co-injection of zvps15-R976Q mutant
mRNA did not ameliorate the phenotypes displayed by the vps15
morphants (Fig. 3c,f). These results show that the zvps15-R976Q
mutant does not complement the ciliopathy phenotypes induced
by zvps15 depletion.
In yeast VPS15-R998Q is linked to trafﬁcking defects. To better
understand the origin of the ciliopathy linked to the hVPS15
mutation, we studied the heterologous expression of hVPS15 and
hVPS15-R998Q mutant in yeast. Human and yeast VPS15
proteins share only 33% identity and the R998 residue is not
conserved in yeast ScVps15 protein15. Although a speciﬁc amino
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acid is frequently not conserved in yeast, the structure and the
function of yeast and human proteins as a whole are closely
related. Humanization of yeast cells by replacing the yeast gene by
its human counterpart is a potent approach used to gain insights
into the cellular role of the human protein20,21. In humanized yeast
cells, we analysed the VPS15-dependent cellular functions such as
growth, intracellular trafﬁcking from the Golgi to the vacuole (VPS
pathway) and autophagy. Wild-type (WT) or vps15D mutant yeast
cells were transformed by plasmids bearing either the wild-type
hVPS15 or mutant hVPS15-R998Q cDNA, allowing either
expression (CEN plasmid) or overexpression (2m plasmid) of the
human cDNA, as controlled by western-blot (Supplementary
Fig. 3F). We observed growth delays upon overexpression of
hVPS15 suggesting that hVPS15 might hijack important cellular
functions (Supplementary Fig. 3H). Autophagy was investigated by
monitoring the maturation of the aminopeptidase Ape1, a
common read-out of yeast autophagy22. We observed that as
previously described autophagy is blocked in the vps15D yeast
mutant cells compared with the wild-type cells, indeed the
aminopeptidase (Api) is not matured (Fig. 3g). However,
although autophagy was impaired in vps15D cells (Fig. 3g), this
defect was not rescued by expression of hVPS15 wild-type or
R998Q mutant (Fig. 3g). Transport to the vacuole along the VPS
pathway was then analysed by using the CMAC ﬂuorescent probe
that normally only labels the lumen of the yeast vacuole
(Supplementary Fig.3G). However, vps15D cells show an
additional CMAC-positive compartment (CPC; white arrows,
Supplementary Fig. 3G) that was not rescued by the expression
of hVPS15-R998Q mutant as efﬁciently as by the wild-type
hVPS15 (Fig. 3h), indicating a default in transport to the vacuole.
These yeast data suggest that the R998Q mutation might impair an
in vivo function of hVPS15 in intracellular trafﬁcking from the
Golgi to the vacuole.
VPS15 and VPS15-R998Q bind to their partners and to GM130.
Having shown that VPS15-R998Q leads to ciliary phenotypes, we
next investigated whether observed defects were due to a loss of
protein interaction. Indeed, VPS15 is known to be involved in
two distinct cellular functions when interacting with different
proteins, the UVRAG/Beclin1 complex involved in endosomal
trafﬁcking and the Atg14L/Beclin1 complex required for
autophagy (Fig. 4a)10,11. Endogenous VPS15 or VPS15-R998Q
was immunoprecipitated from either control or patient ﬁbroblasts
in rich (þ FCS) or serum-deprivation conditions ( FCS) to
induce cilium formation and co-immunoprecipitation of
VPS34 and Beclin1 proteins assessed by western blot
(Supplementary Fig. 4A). The VPS15 protein was detected in the
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input of control and patient cells (in rich and starved conditions)
indicating that the R998Q substitution does not hamper the
stability of VPS15-R998Q. Moreover, VPS34 and Beclin1 proteins
interacted with VPS15 and VPS15-R998Q proteins in both growth
conditions (þ and  FCS), suggesting that the VPS15–VPS34
complex is functional and active to produce PtdIns3P.
Indeed, PtdIns3P-positive structures were detected in the
control and patient ﬁbroblasts transfected with the 2XFYVE-GFP
probe (Supplementary Fig. 4B) that is speciﬁc for PtdIns3P
(ref. 23).
To further analyse the VPS15 protein complexes, VPS15
immunoprecipitation was done on control and patient cells in
rich conditions (þ FCS), proteins speciﬁcally retained on the
VPS15-magnetic beads and not on naked beads (IPneg) were
determined by mass spectrometry (Fig. 4b and Supplementary
Fig. 4C). As previously shown, high amounts of VPS34
and UVRAG were found interacting with VPS15 (control) and
VPS15-R998Q (patients II.1, II.3 and II.5), and so were Beclin1 and
Atg14L, two known interactors of VPS15 (Fig. 4b and
Supplementary Fig. 4C). We also found NRBF2 (Supplementary
Fig.4C), a protein recently identiﬁed as belonging to the
Atg14L–Beclin1 complex24. Protein abundance estimated from
the number of mass spectrometry spectra (Supplementary Fig. 4C)
shows that between the two controls and the three patients, the
efﬁciency with which the different proteins (VPS34, UVRAG,
Beclin1, NRBF2 and Atg14L) were immunoprecipitated
with VPS15 are similar (Fig. 4c). This suggests that the
R998Q substitution does not destabilize speciﬁcally one of these
protein interactions. Interestingly, the cis-Golgi protein GM130
(GOLGA2) was also found among the strongest interactors of
wild-type and mutant VPS15 (Fig. 4c and Supplementary Fig. 4C).
GM130 has not been previously reported as interacting with
VPS15 (http://thebiogrid.org). However, this new interaction is
highly relevant because the cis-Golgi is involved in transport to the
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cilium and GM130 is required for Golgi morphology and
ciliogenesis via its interaction with the centrosomal protein
AKAP450 (ref. 25). To conﬁrm our mass spectrometry data, we
tested whether GM130 can be detected by western blot after
immunoprecipitation of VPS15 from control and patient (II.5)
cells grown in complete medium (þ FCS) or deprived of serum
( FCS; Fig. 5a). We also immunoprecipitated VPS34 from the
same protein extracts to determine whether VPS34 was interacting
with GM130 (Fig. 5a). As controls, VPS15, VPS34, UVRAG and
Atg14L were detected by western blot in the same samples (þ FCS;
Fig. 4b). The results show that only VPS15 is speciﬁcally
interacting with GM130, whereas in the same conditions VPS34
does not interact with GM130 but retains binding to VPS15,
UVRAG and Atg14L (Figs 4b and 5b). To further conﬁrm this
result, we did the reverse immunoprecipitation experiment and
detected VPS15 by western blot in control and patient ﬁbroblasts
after GM130 immunoprecipitation (Supplementary Fig. 5C).
To determine the intracellular localization of VPS15 in ciliary
conditions, control, VPS15-R998Q patient II.5 and BBS4 /
patient ﬁbroblasts were grown in medium without FCS, ﬁxed and
labelled for VPS15 (red) and acetylated a-tubulin (green) before
observation (Supplementary Fig. 5A). The primary cilium is
present after serum deprivation and there is no co-localization
between VPS15 and acetylated a-tubulin in patient and control
cells (Supplementary Fig. 5A). Indeed, VPS15 is rather concen-
trated around the nucleus, suggesting Golgi localization. The
intracellular localization of VPS15 was also analysed by staining
VPS15 (red) and GM130 (green; Fig. 5b). In confocal microscopy,
this staining shows that the pool of VPS15 present at the Golgi
co-localizes with the golgin GM130 in control and patient cells.
Since IFT20 required for ciliary assembly is anchored at the
cis-Golgi by the golgin GMAP210 (ref. 5), immunoﬂuorescence
staining against VPS15 and GMAP210 was done on control (ctrl)
and patient II.5 ﬁbroblasts grown in complete medium (þ FCS)
and after serum deprivation ( FCS; Fig. 5c). This staining
conﬁrms the localization of VPS15 at the Golgi in both rich and
ciliary conditions. In contrast, and as already suggested by the
interaction results (Fig. 4b,c), VPS34 did not co-localize with
GM130 at the Golgi (Supplementary Fig. 5B). These results
indicate that the PtdIns3P kinase VPS34 does not belong to the
GM130–VPS15 cis-Golgi localized protein complex. We decided to
further investigate the cilium-related role of VPS15 at the Golgi.
IFT20 release from the Golgi is reduced in VPS15-R998Q cells.
Some ciliary cargoes are transported from the cis-Golgi to the base
of the cilia in IFT20-dependent vesicles. The IFT20 protein,
belonging to the IFT-B complex, is anchored at the cis-Golgi by the
golgin GMAP210 (refs 5,6), which is redundant with GM130 for
cis-Golgi cargo delivery26. Moreover, partial depletion of IFT20
induces a shorter length of the primary cilia27, a
phenotype similar to the one observed in VPS15-R998Q cells
(Fig. 2). Therefore, we investigated the localization of IFT20 by
immunoﬂuorescence in control and patient ﬁbroblasts upon cilium
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induction ( FCS) or not (þ FCS). In cells grown in complete
medium (þ FCS), IFT20 (red) was detected in vesicles distributed
throughout the cytoplasm and at the cis-Golgi where it co-localized
with GM130 (green). In these conditions, IFT20-positive vesicles
(red) were observed in patient and control cells (Fig. 6a and
Supplementary Fig. 6). However, upon serum deprivation, while
the distribution of IFT20 was similar to the complete medium
conditions in control cells (vesicles and cis-Golgi), signiﬁcantly less
non-Golgi (vesicular) IFT20 was observed in the patient ﬁbroblasts
(Fig. 6a). Indeed, in the latter, IFT20 localization seems restricted
to the Golgi (Fig. 6a and Supplementary Fig. 6A,B). We conﬁrmed
this Golgi localization in patient cells by performing an
immunoprecipitation of IFT20 followed by a western blot against
GMAP210. In both, control and patient ﬁbroblasts, the interaction
between IFT20 and its anchor GMAP210 (ref. 5) was observed
(Supplementary Fig. 6C), conﬁrming that the R998Q missense
mutation does not disrupt the IFT20–GMAP210 interaction. Thus,
the defect observed in patient ﬁbroblasts seems to be localized at
the level of the formation and/or release of IFT20 positive vesicles
from the cis-Golgi. The difference between control and patient
ﬁbroblast is small but signiﬁcative, and even a slight decrease in
transport of cargo to the cilium may result in a decreased cilium
growth and/or altered signalling.
Overall, our results support a new role for VPS15,
independently of VPS34, in the formation/development of the
primary cilium, presumably by altering the IFT20-dependent
Golgi to cilium vesicular transport as this pathway is affected in
cells from patients bearing the R998Q mutation in VPS15.
Discussion
Here, we report a missense mutation in the VPS15 gene
identiﬁed in a unique family presenting with early-onset retinal
degeneration, late childhood kidney failure associated to mild
skeletal developmental features with moderate intellectual
disability. Overall, this clinical presentation, compatible with a
ciliopathy, showed some overlap mainly with the well-known
Senior–Loken and Bardet–Biedl syndromes2. More than a 1000
proteins are probably required for the biogenesis and function
of the vertebrate primary cilium and more than a 100 genes are
now identiﬁed as mutated in ciliopathies (http://www.omim.org).
Over the past 10 years, classical gene identiﬁcation optimized
now by next-generation sequencing strategies have allowed the
identiﬁcation of ciliary genes carrying mutations within different
families such as, for example, BBS syndrome (mutations in BBS1
or BBS10 accounting each for 20% of the families)28. Nowadays,
new ciliopathy causative genes are very likely to be identiﬁed in
very few if not unique families. One explanation could be that the
gene involved may code for an essential protein for which only a
very limited number of mutation sites may be tolerated, the
remaining mutational sites being probably lethal. Here, we report
the ﬁrst family with a missense mutation in the VPS15/PIK3R4
gene. In metazoan (mouse and Drosophila), VPS15 is an essential
gene11,12. The R998Q substitution is predicted to be probably
damaging by the PolyPhen-2 programme13. Indeed, arginine is a
positively charged polar amino acid, frequently involved in salt-
bridges and important for protein binding sites. Thus, a change
from an arginine to a glutamine that is polar and uncharged is
certainly not neutral. The recently solved crystal structure of the
yeast Vps15–Vps34 complex required for trafﬁcking shows that
the Vps15 kinase domain interacts with the Vps34 kinase domain
to regulate its activity15. The WD40 repeat domain of Vps15 is
engaged in interactions that bridge the Vp15/Vps34 heterodimer
with the Atg6/Vps38 sub-complex15. On the basis of this
structure, the kinase domain of Vps15 is probably inactive once
bound to Vps34 because its ATP binding site is not accessible15,
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however in the human VPS15–GM130 complex this kinase
domain might be functional.
The link between VPS15 and cilia was not obvious since VPS15
was mostly shown to be involved in membrane trafﬁcking and
autophagy (Fig. 4). However, it has long been hypothesized that
VPS15 may have additional roles, because yeast results indicate
that some VPS15 acts independently of the two UVRAG–Beclin1
and ATG14L–Beclin1 complexes22. Now with the clear ciliopathy
phenotypes from human patients and zebraﬁsh knockdown
shown in this work, an additional function in ciliogenesis or cilia
function is suggested. Functional assays in patient cells show that
the VPS15-R998Q mutation affects primary cilia length and
IFT20-dependent trafﬁcking from the cis-Golgi. The retinal
degeneration could be due to a trafﬁcking defect at the level of
photoreceptor cells that are ciliated sensory cells. Indeed,
phototransduction proteins such as rhodopsin are transported
through the connecting cilium structure to the outer segment by
vesicular trafﬁcking involving the IFT machinery29. IFT20 is
required for assembly and maintenance of the photoreceptor
outer segment and likely participates both as component of IFT
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particle and as a cis-Golgi speciﬁc effector independent of
canonical IFT machinery30. On the basis of retinal phenotypes in
patients, we hypothesize that VPS15 is a novel actor in the
photoreceptor transport machinery. Further investigations are
necessary to deﬁne the role of VPS15 compared with other
effectors involved in this trafﬁcking. VPS15 could also be a novel
regulator of the ciliary transport machinery in the kidney tubules,
since a conditional knockout for IFT20 in mice shows rapid
development of kidney cysts31.
Here, we have identiﬁed a novel protein complex localized at the
cis-Golgi and encompassing VPS15 and the golgin GM130. This
new VPS15–GM130 complex could be involved in IFT20-
dependent trafﬁcking to the cilium (Fig. 6b). Indeed, a pool of
IFT20 is associated with the cis-Golgi where it co-localizes partially
with GM130 with increased IFT20 release from the Golgi in
control ﬁbroblast than in patient cells. Golgi-associated IFT20 is
required for cilia assembly6. Interestingly, in mammalian cells,
strong IFT20 knockdown results in a lack of cilia assembly6 and
weaker IFT20 knockdown in shorter primary cilia27 and impaired
transport of cargo to the cilia6. Thus, even a moderate decrease in
the amount of IFT20 involved in the cis-Golgi to cilium transport
could have a tremendous effect on the primary cilium assembly
and function.
Golgins are key Golgi effectors since they participate to the
speciﬁcity of intracellular trafﬁcking by capturing vesicles of
different origins32. At the cis-Golgi level, the golgin GMAP210
serves as an anchor for IFT20 (ref. 5) and knockdown of
GMAP210 leads to a defect in cilia formation5. However, the
knockdown of GM130 has been described as not affecting cilia
assembly33. Interestingly, recent data show that GMAP210 is
redundant with GM130 for cargo delivery to the cis-Golgi26.
Indeed, among the 10 widely conserved golgins tested, only
GM130 and GMAP210 were shown to be speciﬁc for tethering
vesicles arriving at the cis-Golgi from the endoplasmic reticulum32.
Thus, more redundancy in the function of these two proteins
might exist, especially at the level of primary cilium formation/
function. Another argument playing in favour of a role of GM130
in ciliogenesis is its interaction with the centrosomal protein
AKAP450, an interaction required for ciliogenesis and Golgi
integrity25. Thus, GM130 role may be less direct than GMAP210
and could involve additional proteins. Here, we show that the
VPS15 kinase interacts with GM130 and that in VPS15-R998Q
patient cells IFT20 is partially retained in the Golgi. Thus, the
VPS15–GM130 protein complex could serve as platform to form
IFT20-positive vesicles targeted from the cis-Golgi to the cilium.
Mass spectrometry analyses aimed at unravelling the molecular
mechanism of VPS15 function in cilium formation indicate that
indeed, although the VPS15–GM130 interaction is conserved
between control and patient ﬁbroblasts, a GM130–IFT20
interaction was detected in control ﬁbroblasts but never in
patient cells (by three independent experiments). Additional
research along this line of work is needed to conﬁrm this
hypothesis.
Misbalanced trafﬁcking to the cilia has dramatic consequences
on cilia assembly and function, resulting in ciliopathies. Among
the trafﬁcking effectors involved, the BBSome, a complex formed
by a subset of BBS proteins, is altered in a signiﬁcant number of
patients with Bardet–Biedl syndrome. The cilia trafﬁcking
pathway is still poorly understood, yet very important for proper
signalling functions4. During evolution and to ensure intracellular
trafﬁcking, different coat complexes have assembled; among them
are the clathrin, COPI/COPII and BBSome coat that share a
common overall structure8. The VPS15–VPS34 platform is
crucial for trafﬁcking and this assembly platform is well
conserved during evolution. VPS15 could also be involved at
the cis-Golgi to serve as a platform for ciliary-targeted membrane
proteins. Indeed, GMAP210 and GM130 golgins are not speciﬁc
for ciliary cargoes, thus other proteins are involved to control this
speciﬁcity and VPS15 or an interaction partner could be good
candidates (Fig. 6b).
Overall, our results support a new role for VPS15, independent
of VPS34, in the IFT20-dependent Golgi to cilium vesicular
transport as this pathway is affected in patients bearing the VPS15-
R998Q mutation. However, VPS15 does not directly interact with
IFT20 and its interaction with GM130 is not hampered by the
presence of the point mutation either. Therefore, subsequent work
will be needed to analyse the interactions between IFT20 and
the VP15–GM130 complex to conﬁrm VPS15-dependent IFT20–
GM130 interaction. Thus, the potential involvement of partners of
the VPS15–GM130 complex whose function might be hampered
by the patient mutation in VPS15 will need further investigations.
Methods
Ethical approval. After informed consent of the patient and his/her representative
according to the French legislation, peripheral blood samples were obtained from
the affected children and their parents as well as control individuals. DNA from all
the collected samples was extracted according to standard procedures. The
objectives and the aim of the study were clearly explained to the patients and this
study was approved by the local ethics committee at Hoˆpitaux Universitaires de
Strasbourg (Strasbourg University Hospital).
Cell cultures. Fibroblasts of patients and age-matched healthy control individuals
were obtained by skin biopsy, as previously described34. Primary skin ﬁbroblasts
from VPS15-R998Q patients and age-matched healthy control skin ﬁbroblasts, as
well as the hTERT-RPE1 cell line were grown in DMEM supplemented with 10%
fetal calf serum (FCS) and 1% PSG (penicillin–streptomycin–glutamin). To induce
primary cilium formation, the cells were deprived of serum by growth for 24 h in
DMEM with 1% PSG but only 0.1% FCS (conditions:  FCS).
250K Affymetrix array and Sanger sequencing. To identify the genetic mutation
responsible for the disease, we screened a panel of 30 ciliopathy-related genes by
targeted exon-capture strategy coupled with multiplexing and high-throughput
sequencing35, and we found no mutations. Then, we performed a genome-wide
homozygosity mapping using GeneChip Human 250K SNP Affymetrix
(Supplementary Fig. 1) combined to whole-exome sequencing (Agilent SureSelect
All Exon XT2 50 Mb kit) of the three affected siblings (II.1, II.3, II.5) and the healthy
sister (II.4), using the facilities provided by IntegraGen (Evry, France). Sequencing
data processing and variant calling (SNP and InDels) with the Genome Analysis
Toolkit revealed 60,612 to 63,887 genetic variants per proband (Supplementary
Table 1). Variant ﬁltering was performed with the VaRank programme36 using
stringent criteria excluding (i) non-pathogenic variants deﬁned in dbSNP 138,
(ii) variants represented with an allele frequency of more than 1% in dbSNP, the
Exome Variant Server, the Thousand Genomes Project Catalog and the ExAC
database, (iii) variants found in the homozygous state or more than once in the
heterozygous state in 70 control exomes, (iv) variants into 50-UTR (untranslated
region), 30-UTR, downstream, upstream or intron locations without local splice
effect prediction, (v) synonymous variants without local splice effect prediction. This
step reduced the number of genetics variants to 1,085, 793, 1,124 and 2,009 variants,
respectively, per proband (Supplementary Table 1). The variant and its cosegregation
with the phenotype in the family was conﬁrmed by Sanger sequencing. Sanger
sequencing was performed by way of PCR ampliﬁcation with 50ng of genomic
DNA template. The primers were designed with Primer 3 (http://frodo.wi.mit.edu/
primer3) and are detailed in Supplementary Table 2. Bidirectional sequencing of the
puriﬁed PCR products was performed by GATC Biotech. Segregation analysis ruled
out the mutations in the RECQL4/MFSD3 gene as they were both carried in cis by a
maternal chromosome. The very closely related intronic AK9 insertions of six or four
nucleotides (NM_001145128.2:c.5315þ 104_5315þ 105insAGAGAG and
NM_001145128.2:c.5315þ 106_5315þ 107insAGAG) in a repetition of an AG
motif in intron 38 are present in the three patients and in the healthy sister and thus
not speciﬁc to the disease.
Zebraﬁsh experiments. Fish were bred and raised at 28.5 C as described
previously37. The AB wild-type line (University of Oregon, Eugene) was used for all
the experiments. Sexually mature ﬁsh were crossed in couples, and the eggs were
collected after being laid. For experiments, fertilized eggs were raised in 1 Instant
Ocean salt solution (Aquarium Systems, Inc.) supplemented with 200 mM 1-phenyl
2-thiourea to suppress melanogenesis.
The pik3R4/vps15 full-length sequence was ampliﬁed with the pikwt-forw and
pikwt-rev primers (Supplementary Table 2) and cloned into pCS2þGFP with
EcoRI-XhoI. pGEM T-easy vector containing the 1,100 bp fragment used for whole
mount was cut with EcoRI, and the resulting fragment cloned into pCS2þGFP to
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give the zVps15-GFP plasmid. For zvps15-RQ mutant, we ampliﬁed the wild-type
sequence with pikmut-forw/pikwt-forw and pikmut-rev/pikwt-rev (Supplementary
Table 2). The two obtained fragments were then ampliﬁed together with a mix of
pikwtforw/pikwtrev and ﬁnally cloned into pCS2þGFP with EcoRI-XhoI.
RT–PCR (PCR with reverse transcription) was carried out following standard
protocol. Total RNA was isolated from 24 to 72 h.p.f. embryos using Tri-reagent
(Invitrogen, Carlsbad, CA, USA). For zvps15 in situ hybridization, we used as probe
a fragment of 1,100 bp ampliﬁed by PCR with the following primers pik3r4WM-
forw and pik3r4WM-rev and cloned into pGEM-T-easy vector (Promega). For
RNA probe, we used NcoI and SP6 RNA polymerase. RT–PCR was done with the
same primer pairs.
Whole-mount in situ hybridization was performed as previously described38.
To prevent pigmentation for expression analysis after 24 h.p.f., embryos were
transferred to water containing 0.2mM 1-phenyl-2-thiourea at 20 h.p.f. and ﬁxed at
appropriate stages.
For injections, the zebraﬁsh eggs were collected shortly after being laid. The
cleaned eggs were transferred to a petri dish with a minimal amount of water.
The embryos were injected (FemtoJet; Eppendorf) through the chorion into the
yolk at the one-cell stage with 12 nl of solution. The injection needles were pulled
from borosilicate glass capillary tubes with ﬁlament (Warner Instruments) using a
micropipette puller (Sutter Instrument Co). Morpholinos (Gene Tools, LLC) were
injected at the following concentrations: vps15-mo: 50-AGTTGGTTCCCCA
TCTCACTGGATC-30 (0.4mM); p53-mo: 50-GCGCCATTGCTTTGCAAGA-AT
TG-30 (0.4mM); vps15cont-mo: 50-AGTaGcTT CCCgATCTCAgTcGATC-30
(0.4mM). All the dilutions were made in distilled water. Phenol red was added to
the samples before injection (0.1% ﬁnal concentration). zVps15-GFP plasmid was
injected at the ﬁnal concentration of 40 ng ml 1. zvps15 wild-type and zvps15-
R976Q mRNA were injected at the ﬁnal concentration of 40 ng ml 1.
Materials and methods for yeast cells. The R998Q mutation was introduced
into the hVPS15 cDNA by polymerase chain reaction (PCR) with Phusion High-
Fidelity DNA polymerase (Thermo Scientiﬁc) on the pDONR223 entry vector
bearing hVPS15 cDNA (Addgene 23488). The resulting pDONR223-hVPS15-
R998Q or pDONR223-hVPS15 were cloned by the Gateway LR reaction (Invi-
trogen) into yeast destination vectors (Addgene plasmid numbers 14,196 and
14,252; ref. 39) to obtain the pSF194 (pAG423-promGPD-hVPS15-R998Q) and
pSF196 (pAG413-promGPD-hVPS15-R998Q) or pSF198 (pAG423-promGPD-
hVPS15) and pSF199 (pAG413-promGPD-hVPS15) plasmids. All the plasmids
sequences were veriﬁed by sequencing (GATC Biotech).
S. cerevisiae strains used in this study are BY4742 WT (MATa leu2D0 ura3D0
his3D0 lys2D0), vps15D (BY4742 vps15::kanMX) and atg5D (BY4742 atg5::kanMX).
The indicated yeast strain were grown at 30 C to mid-exponential growth
phase in rich medium (YPD): 1% yeast extract, 2% peptone, 2% glucose or in
synthetic-deﬁned medium: 0.67% yeast nitrogen base (YNB) without amino acids,
2% glucose and the appropriate dropout mix. Autophagy was induced by
incubation for 4 h in synthetic-deﬁned-N medium: 0.17% (YNB) without
ammonium sulfate, 2% glucose. Yeast cells were transformed using the modiﬁed
lithium acetate method.
Living cells expressing hVPS15 or hVPS15-R998Q were harvested at an D600nm
0.5–1 and resuspended in synthetic complete yeast medium before visualization.
For CMAC (Invitrogen) staining, the indicated yeast strain was harvested by a 500g
centrifugation for 1min, resuspended in synthetic deﬁned medium and stained
with CMAC (33 mM) for 10min at 30 C before washing with phosphate-buffered
saline (PBS). Observation was performed with 100X/1.45 oil objective (Zeiss) on a
ﬂuorescence Axio Observer D1 microscope (Zeiss) using DAPI ﬁlter and DIC
optics. Images were captured with a CoolSnap HQ2 photometrix camera (Roper
Scientiﬁc) and treated by ImageJ (Rasband W.S., ImageJ, U.S. National Institutes of
Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/). For western-blot analysis,
total yeast extracts were obtained by NaOH lysis followed by TCA precipitation as
previously described40. The equivalent of 1.5 D600nm unit of yeast cells were
resuspended in 50ml of 2X Laemmli buffer plus Tris Base. The samples were
incubated for 5min at 37 C and analysed by 10% SDS–polyacrylamide gel
electrophoresis followed by immunoblotting with anti-hVPS15 (Novus Bio,
NBP1-30463) or anti-Ape1 (also termed Api, kind gift from Daniel Klionsky) using
the standard procedures. The images were acquired with the ChemiDoc Touch
Imaging System (Bio-Rad).
Immunoﬂuorescence. Primary ﬁbroblasts from patients and control individuals
were grown in Nunc Lab-Tek chamber slides (Thermo Scientiﬁc) or on spot slides,
deprived of FCS for 24 h (or not) and ﬁxed with 4% paraformaldehyde. After
incubation with 0.5% Triton X-100 for 10min, and blocking in PBS-20% FCS, the
cells were incubated for 1 h with primary antibodies, washed three times in PBS,
incubated for 1 h with secondary antibodies and DAPI, washed again in PBS and
mounted in Elvanol No-Fade mounting medium before observation. Primary cilia
were labelled with an antibody directed against acetylated a-tubulin highlighting
the axoneme41. Primary antibodies against acetylated a-tubulin (Abcam, ab24610),
VPS15 (Novus Bio, NBP1-30463), VPS34 (Cell Signaling, 4263), GM130 (Abcam,
ab169276), GMAP210 (Thermo Scientiﬁc, MA1-23294), IFT20 (Proteintech,
13615-1-AP) and HA (Roche, 1867423) were used. Secondary antibodies were goat
anti-mouse Alexa Fluor coupled (either 488 or 568) IgG (Invitrogen), goat anti-rat
Alexa Fluor 488 coupled IgG (Abcam, ab150157), donkey anti-rabbit IgG-FITC
(Santa Cruz sc-2090) and donkey anti-mouse IgG (Hþ L) FITC conjugate
(Thermo Scientiﬁc A16012). The cells were observed on a ﬂuorescence
(Zeiss Axio Observer D1) or confocal (Zeiss LSM700,  40 objective, Plateforme
Microscopie et Imagerie (IBMP, Strasbourg, France)) microscope and images
processed with ImageJ. The cilia length from the base to the tip was measured
using the ImageJ program on confocal images, and the length of each primary
cilia was determined for 120 to 200 cells per sample (ctrl1, ctrl2, ctrl3, II.1, II.3, II.5
and BBS4 / ).
Transient transfection for GFP-2XFYVEHRS and VPS15-HA plasmids. The
ﬁbroblasts cells were cultured to be 60% conﬂuent the day of transfection in
Nunc Lab-Tek chamber slides (Thermo Scientiﬁc). Five hundred nanograms of
plasmid was transfected using the DNA transfection reagent (jetPEI, Polyplus
transfection) according to the protocol for adherent cells. After 24 h, the ﬁbroblast
cells were washed three times in PBS, then the cells were ﬁxed for 30min at room
temperature with 4% paraformaldehyde, rinsed three times in PBS for 5min
each, stained with DAPI and confocal ﬂuorescence microscopy was done.
Confocal microscopy was performed on a Zeiss LSM700 microscope. The
GFP-2XFYVEHRS plasmid was a kind gift from Harald Stenmark. The
VPS15-HA plasmid was obtained by cloning the pDONR223-hVPS15 described
above into the human destination vector pCSf107mT-GATEWAY-30-3HA
(Addgene, 67616) by the Gateway LR reaction (Invitrogen). Plasmid was veriﬁed by
sequencing.
Co-immunoprecipitation and mass-spectrometry analysis. The cells were
grown in DMEM (Catalogue no. 31885; Gibco Invitrogen), 10% FBS and penicillin
and streptomycin (P/S) to full conﬂuence. To induce primary cilia, the cells were
grown to conﬂuence in DMEM containing 10% FCS, then washed with PBS and
starved by serum deprivation for 24 h with DMEM 0.1% FCS. Before lysis, the cells
were rinsed with PBS at 4 C, resuspended in non-denaturing lysis buffer
(20mM Tris HCL pH 8; 137mM NaCl; 1% Nonidet P-40; 2mM EDTA) with a
protease inhibitor cocktail (Roche 06538282001) and incubated on ice for 15min
under gentle shaking. The samples were then centrifuged at 12,000g for 20min at
4 C, protein concentration was measured using Qubit Protein Assay Kit
(Life Technologies). Five hundred micrograms of cell lysates were incubated with
VPS15 antibodies (Novus Biologicals NBP1-30463) on a rocker shaker overnight at
4 C. The immunocomplexes were captured by protein G sepharose beads
(Dutcher 17-0618-05) for 2 h at 4 C under gentle shaking. Sepharose G beads were
washed 6 5min with non-denaturing lysis buffer with a protease inhibitor
cocktail, resuspended in 2X Laemmli buffer and boiled for 10min at 95 C to
dissociate the immunocomplexes from the beads. For western blot, the same
primary antibodies as for immunoﬂuorescence were used, and anti-GMAP210
(Thermo Scientiﬁc, #MA1-23294), anti-Beclin1 (Cell Signaling, #3495),
anti-Atg14L (Cell Signaling, #5504), anti-UVRAG (Abcam, #ab174550) and
anti-GAPDH (Abcam, #ab181602) antibodies were also used. For the VPS15-HA
control experiment, immunoprecipitation was done with the anti-HA antibody
used for immunoﬂuorescence and western blot detection with a mouse anti-HA
antibody (Abcam,ab130275). Uncropped images of the western blots are shown in
Supplementary Fig. 7 and Supplementary Fig. 8.
For mass-spectrometry analyses, endogenous VPS15 immunoprecipitation was
carried out with mMACS Protein A/G microbeads (Miltenyi Biotec) and VPS15
antibody (Novus Biologicals NBP1-30463), according to the manufacturer’s
protocol. Each protein sample was split in half. The second halves were used as
negative controls, omitting antibodies during the immunoprecipitations (IPneg).
Proteins complexes were eluted out of the magnetic stand with the SDS gel-loading
buffer from the kit. Co-immunoprecipitation experiments were carried out in
replicates for all the samples (two healthy controls and the three patients). The
samples were prepared for mass spectrometry analyses as previously described42.
Brieﬂy, eluted proteins were precipitated with 0.1M ammonium acetate in 100%
methanol. After a reduction-alkylation step (dithiothreitol 5mM–iodoacetamide
10mM), proteins were digested overnight with 1/25 (W/W) of modiﬁed
sequencing-grade trypsin (Promega, Madison, WI, USA) in 50mM ammonium
bicarbonate. Resulting peptides were vacuum-dried in a SpeedVac concentrator
and re-suspended in water containing 0.1% FA (solvent A) before being injected on
nanoLC-MS/MS (NanoLC-2DPlus system with nanoFlex ChiP module; Eksigent,
ABSciex, Concord, Ontario, Canada, coupled to a TripleTOF 5600 mass
spectrometer (ABSciex)). Peptides were eluted from the C-18 analytical column
(75 mm ID 15 cm ChromXP; Eksigent) with a 5–40% gradient of acetonitrile
(solvent B) for 90min.
The data were searched against the complete Human proteome set from the
SwissProt database (released 2013/01/09; 43.964 sequences). Peptides were
identiﬁed with Mascot algorithm (version 2.2, Matrix Science, London, UK)
through the ProteinScape 3.1 package (Bruker). They were validated with a
minimum score of 30, a P value o0.05 and a decoy database strategy was used to
validate Mascot identiﬁcations at FDRo1%. For this study, selected protein
partners were considered according to the following rule: presence in the ﬁve
co-immunoprecipitation , absence from all the negative controls. They are sorted
by decreasing average number of spectra.
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Antibodies. Detailed information on antibodies used in this study as well as their
dilution are indicated in Supplementary Table 3.
Data availability. The whole-exome sequencing data have been deposited
at the European Genome-Phenome Archive (EGA), which is hosted by the
European Bioinformatics Institute (EBI) and the Centre for Genomic
Regulation (CRG), under accession number EGAS00001002075. The rest of the
data that support the ﬁndings of this study are available from the corresponding
authors on request.
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